
- ONCOLOGY Vol 15 No 6
- Volume 15
- Issue 6
ASCO Welcomes Tobacco Bill
The American Society of Clinical Oncology (ASCO) is backing legislation (H.R. 1097) that would give the Food and Drug Administration (FDA) the authority to regulate tobacco products. The legislation explicitly states that nicotine should be
The American Society of Clinical Oncology (ASCO) is backinglegislation (H.R. 1097) that would give the Food and Drug Administration (FDA) the authority to regulate tobacco products. The legislationexplicitly states that nicotine should be regulated as a drug, and tobaccoproducts as drug delivery devices. The legislation also gives the FDA theauthority to regulate tobacco product advertising and promotion. Reps. GregGanske (R-Iowa), John Dingell (D-Mich), and Henry Waxman (D-Calif) are theprimary sponsors.
"We greatly appreciate the consistent leadership Reps.Ganske, Dingell, and Waxman provide on behalf of the federal regulation oftobacco products," said an ASCO statement. "Smoking accounts for atleast 30% of all cancer deaths, is a major cause of heart disease, and isassociated with conditions ranging from colds and gastric ulcers to chronicbronchitis, emphysema, and cerebrovascular disease."
Articles in this issue
over 24 years ago
Coverage for New Oral Cancer Drugsover 24 years ago
Low Doses of Zoledronic Acid Reduce Complications of Bone Metastasesover 24 years ago
Barriers to Clinical Trial Enrollmentover 24 years ago
Tamoxifen Does Not Affect Sexual Functioning or Mood Swingsover 24 years ago
Risk Factors for Relapse of Cutaneous Melanomaover 24 years ago
Outline of Oncology Therapeuticsover 24 years ago
Atlas of Cancer Surgeryover 24 years ago
Patient Care Costs in Cancer Clinical Trialsover 24 years ago
Dose Intensity for Breast Cancerover 24 years ago
Recent Developments in Chemotherapy for Bladder CancerNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































